These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 28343650)

  • 21. [Identification of abuse/dependence cases by the French addictovigilance network (FAN): A pilot study of the addictovigilance center and the psychotherapeutic center of Nancy (France)].
    Barberot P; Gibaja V; Benkhedda C; Dobre D; Tournebize J; Kahn JP
    Therapie; 2019 Jun; 74(3):389-397. PubMed ID: 30392700
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Uro- and nephrotoxic effects of drugs of abuse: Literature review and pharmaco-epidemiological survey in France and in the Marseille area].
    Gully M; Frauger É; Spadari M; Pochard L; Pauly V; Romain F; Gondouin B; Sallée M; Moussi-Frances J; Burtey S; Dussol B; Daniel L; Micallef J; Jourde-Chiche N
    Nephrol Ther; 2017 Nov; 13(6):429-438. PubMed ID: 28958905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Consumption of cannabis among subjects with history of abuse/dependence or under an opiate maintenance therapy: OPPIDUM data in 2006 and main trends since 2004].
    Frauger E; Vigneau C; Orléans V; Thirion X; Jolliet P; Micallef J; Réseau des CEIP
    Therapie; 2008; 63(2):119-27. PubMed ID: 18561886
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Recent evolution in opiate dependence in France during generalisation of maintenance treatments.
    Thirion X; Micallef J; Barrau K; Djezzar S; Lambert H; Sanmarco JL; Lagier G
    Drug Alcohol Depend; 2001 Feb; 61(3):281-5. PubMed ID: 11164692
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estimated magnitude of diversion and abuse of opioids relative to benzodiazepines in France.
    Pauly V; Pradel V; Pourcel L; Nordmann S; Frauger E; Lapeyre-Mestre M; Micallef J; Thirion X
    Drug Alcohol Depend; 2012 Nov; 126(1-2):13-20. PubMed ID: 22475815
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Not Available].
    Modelon H; Frauger E; Laurenceau D; Thirion X; Mallaret M; Micallef J;
    Therapie; 2007; 62(4):337-46. PubMed ID: 27393493
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Addictovigilance contribution during COVID-19 epidemic and lockdown in France.
    Lapeyre-Mestre M; Boucher A; Daveluy A; Gibaja V; Jouanjus E; Mallaret M; Peyrière H; Micallef J;
    Therapie; 2020; 75(4):343-354. PubMed ID: 32660776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Interest of large electronic health care databases in addictovigilance: Lessons from 15 years of pharmacoepidemiological contribution.
    Dupui M; Micallef J; Lapeyre-Mestre M
    Therapie; 2019 Apr; 74(2):307-314. PubMed ID: 30798951
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Signal identification in addictovigilance: the functioning of the French system.
    Jouanjus E; Gibaja V; Kahn JP; Haramburu F; Daveluy A
    Therapie; 2015; 70(2):113-31. PubMed ID: 25858567
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evidence of slow-release morphine sulfate abuse and diversion: epidemiological approaches in a French administrative area.
    Peyriere H; Nogue E; Eiden C; Frauger E; Charra M; Picot MC;
    Fundam Clin Pharmacol; 2016 Oct; 30(5):466-75. PubMed ID: 27315486
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Abuse Liability of Quetiapine (Xeroquel®)].
    Peyrière H; Diot C; Eiden C; Petit P;
    Therapie; 2015 Aug; ():. PubMed ID: 26242499
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antidepressants abuse in subjects with opioid use disorders: A 10-year study in the French OPPIDUM program.
    Dumonceau RG; Soeiro T; Lacroix C; Giocanti A; Frauger É; Mezaache S; Micallef J
    Fundam Clin Pharmacol; 2022 Apr; 36(2):436-442. PubMed ID: 34837277
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Dependence on psychotropic drugs and substitution treatment: recent trends. The OPPIDUM study of the Centers for Evaluation and Information on Drug Dependence (CEIP), October 1997].
    Thirion X; Micallef J; Guet F; Delarozière JC; Arditti J; Huntsman A; Sanmarco JL; Lagier G
    Therapie; 1999; 54(2):243-9. PubMed ID: 10394261
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Not Available].
    Frauger E; Vigneau C; Orléans V; Thirion X; Jolliet P; Micallef J; le Réseau des Ceip
    Therapie; 2008; 63(2):119-27. PubMed ID: 27393730
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Example of an investigation of an "emergent" phenomenon in addiction vigilance: the case of methylphenidate.
    Micallef J; Frauger E; Palmaro A; Boucherie Q; Lapeyre Mestre M
    Therapie; 2015; 70(2):191-202. PubMed ID: 25858575
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Current situation on new psychoactive substances abuse among methadone maintenance treatment patients in China].
    Cheng Z; Dai MM; Cao XB
    Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Apr; 39(4):536-540. PubMed ID: 29699053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gabapentinoid Abuse in France: Evidence on Health Consequences and New Points of Vigilance.
    Tambon M; Ponté C; Jouanjus E; Fouilhé N; Micallef J; Lapeyre-Mestre M;
    Front Psychiatry; 2021; 12():639780. PubMed ID: 33613345
    [No Abstract]   [Full Text] [Related]  

  • 38. [From psychoactive medicines to addictovigilance in French Public Health Code (1990-2017)].
    Baumevieille M; Perri-Plandé J; Miremont-Salamé G; Daveluy A; Haramburu F
    Therapie; 2019 Jun; 74(3):375-382. PubMed ID: 30193805
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Health consequences of cocaine use in France: data from the French Addictovigilance Network.
    Eiden C; Vincent M; Serrand C; Serre A; Richard N; Picot MC; Frauger E; Fouilhé N; Daveluy A; Peyrière H;
    Fundam Clin Pharmacol; 2021 Apr; 35(2):455-465. PubMed ID: 32854152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Identification and tracking of Addictovigilance signals in general practice: which interactions between the general practitioners and the French Addictovigilance Network?
    Gentile G; Jego M; Spadari M; Griffiths K; Jouanjus E; Micallef J
    Fundam Clin Pharmacol; 2018 Dec; 32(6):643-651. PubMed ID: 30003596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.